CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions

Remyelination in multiple sclerosis (MS) occurs spontaneously and extensively. The underlying mechanisms, however, are only partly understood. Findings in experimental animal settings suggest that inflammation promotes remyelination and repair. Here, we characterized the chemokine receptor expression profiles of macrophages/microglia in early remyelinating and completely remyelinated lesions compared with active demyelinating and inactive demyelinated MS lesions obtained in the early disease course. Biopsy material consisting of 16 MS cases was available for this study. We found that macrophages/microglia within early remyelinating lesions expressed predominantly CCR5. Our findings implicate a possible role of CCR5+ cells in initiating remyelination.

• Publication year

  2008

• Venue

  Multiple Sclerosis

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1352458508089359PMID 18611987
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myelin‐phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype

  2008cited by this paper
• Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury

  2008cited by this paper
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• Remyelination In Multiple Sclerosis

  2007cited by this paper
• Remyelination is extensive in a subset of multiple sclerosis patients.

  2006cited by this paper
• Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.

  2006cited by this paper
• CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis

  2005cited by this paper
• Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression.

  2005cited by this paper
• Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.

  2005cited by this paper
• CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

  2005cited by this paper
• Influence of C C R5 δ32 polymorphism on multiple sclerosis susceptibility and disease course

  2004cited by this paper
• Association of CCR5 delta32 deletion with early death in multiple sclerosis.

  2004cited by this paper
• Expression of CCR7 in multiple sclerosis: Implications for CNS immunity

  2004cited by this paper
• Expression of Chemokine Receptors CCR1 and CCR5 Reflects Differential Activation of Mononuclear Phagocytes in Pattern II and Pattern III Multiple Sclerosis Lesions

  2004cited by this paper
• Association of CCR5 Δ32 deletion with early death in multiple sclerosis

  2004cited by this paper
• Remyelination in multiple sclerosis.

  2003cited by this paper
• Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration

  2003cited by this paper
• Alterations in metabolism and gene expression in brain regions during cuprizone‐induced demyelination and remyelination

  2002cited by this paper
• CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

  2001cited by this paper
• Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier1

  2001cited by this paper
• Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin‐induced demyelination

  2001influential reference
• CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.

  2000cited by this paper
• Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

  1999cited by this paper
• The CCR5 deletion mutation fails to protect against multiple sclerosis.

  1997cited by this paper
• Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis

  1996cited by this paper
• Monocyte/macrophage differentiation in early multiple sclerosis lesions

  1995cited by this paper

• TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease.

  2024cites this paper
• The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings

  2024cites this paper
• CCR5 and Inflammatory Storm.

  2024cites this paper
• Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis.

  2023cites this paper
• Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair

  2021cites this paper
• TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells

  2021cites this paper
• Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis

  2020cites this paper
• THE EXPRESSION AND CELLULAR LOCALIZATION OF CC-CHEMOKINE RECEPTOR 5 (CCR5) AFTER TRAUMATIC BRAIN INJURY

  2020cites this paper
• Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

  2019cites this paper
• A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis

  2018cites this paper
• Distinct NG2 proteoglycan-dependent roles of resident microglia and bone marrow-derived macrophages during myelin damage and repair

  2017cites this paper
• The balance between cathepsin C and cystatin F controls remyelination in the brain of Plp1‐overexpressing mouse, a chronic demyelinating disease model

  2017cites this paper
• Développement de méthodes d’IRM avancées pour l’étude longitudinale de la Sclérose en Plaques

  2017cites this paper
• Weekly follow up of acute lesions in three early multiple sclerosis patients using MR spectroscopy and diffusion.

  2017cites this paper
• Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.

  2016cites this paper
• Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair

  2016cites this paper
• Corrigendum: Oligodendrocyte, Astrocyte and Microglia Crosstalk in Myelin Development, Damage, and Repair

  2016cites this paper
• Microglia Function in the Normal Brain.

  2016cites this paper
• IFN-β and multiple sclerosis: cross-talking of immune cells and integration of immunoregulatory networks.

  2015cites this paper
• NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair

  2015cites this paper
• Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System

  2014cites this paper
• The chemokine receptor CCR5 Δ32 allele in natalizumab‐treated multiple sclerosis

  2014cites this paper
• Genetic and Epigenetic Regulation of CCR5 Transcription

  2012cites this paper
• Genetic and Epigenetic Regulation of CCR 5 Transcription

  2012cites this paper
• Neuroinflammation rapidly triggers long-term modulation of synaptic transmission

  2012cites this paper
• G protein-coupled receptors as therapeutic targets for multiple sclerosis

  2012cites this paper
• Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors

  2012cites this paper
• CCL5 induces a pro-inflammatory profile in microglia in vitro.

  2011cites this paper
• Physiology of microglia.

  2011cites this paper
• Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration

  2011cites this paper
• Znaczenie wybranych populacji komórek immunologicznych w leczeniu zaostrzeń stwardnienia rozsianego z zastosowaniem plazmaferezy

  2011cites this paper
• Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis.

  2010cites this paper
• THE EXPRESSION AND CELLULAR LOCALIZATION OF CC-CHEMOKINE RECEPTOR 5 (CCR5) AFTER TRAUMATIC BRAIN INJURY

  2010cites this paper
• Protective effects of microglia in multiple sclerosis.

  2010cites this paper
• Restoring immune suppression in the multiple sclerosis brain.

  2009cites this paper
• Memory and naïve B-cell subsets in patients with multiple sclerosis.

  2009cites this paper
• Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target

  2009cites this paper
• Microglia: gatekeepers of central nervous system immunology

  2009cites this paper
• Cytokines and Myelination in the Central Nervous System

  2008cites this paper